18-mer-HP

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug Name18-mer-HP
Drug Alias Name18-mer-HP
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHigh Mobility Group Protein B1 inhibitorsAdvanced glycosylation end product-specific receptor antagonists
TargetsHigh Mobility Group Protein B1Advanced glycosylation end product-specific receptor
Therapy Area/IndicationsLiver Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of North Carolina At Chapel Hill
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of North Carolina At Chapel Hill
Inactive CompaniesN/A
Active IndicationsLiver Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A